J. Gotts

Epidemiology · 2014–2016

A researcher in the Science corpus: 2 papers; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom J. Gotts trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Kevin J. Tracey
  2. J. Marshall
  3. Jean-Louis Vincent
  4. Mitchell M. Levy

Who trusts J. Gotts overall

  1. Chao Yu

Papers from J. Gotts's perspective

Ordered by how strongly the researchers J. Gotts trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care (Critical Care Medicine)
  2. Hydrocortisone therapy for patients with septic shock. (New England Journal of Medicine)
  3. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock (Current Infectious Disease Reports)
  4. Efficacy and safety of recombinant human activated protein C for severe sepsis. (New England Journal of Medicine)
  5. The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis (Intensive Care Medicine)
  6. Immunologic and hemodynamic effects of "low-dose" hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study. (American Journal of Respiratory and Critical Care Medicine)
  7. Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death. (New England Journal of Medicine)
  8. Early Goal-Directed Therapy in the Treatment of Severe Sepsis and Septic Shock
  9. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock (Critical Care Medicine)
  10. Drotrecogin alfa (activated) in adults with septic shock. (New England Journal of Medicine)

Their papers